| Stage | TJX | % of rev | LE | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $15.2B | 100.00% | $302M | 100.00% | TJX ×50.26 |
| Gross profit | $5.1B | 33.41% | $157M | 51.99% | LE +18.6pp |
| Operating income | $2.0B | 13.09% | $4M | 1.31% | TJX +11.8pp |
| Pre-tax income | $2.0B | 13.29% | $8M | 2.72% | TJX +10.6pp |
| Net income | $1.5B | 10.01% | $3M | 1.14% | TJX +8.9pp |
| Stage | TJX | LE | Gap · A − B |
|---|---|---|---|
| Revenue | $15.2B100.00% | $302M100.00% | TJX ×50.26 |
| Gross profit | 33.41%$5.1B | 51.99%$157M | LE +18.6pp |
| Operating income | 13.09%$2.0B | 1.31%$4M | TJX +11.8pp |
| Pre-tax income | 13.29%$2.0B | 2.72%$8M | TJX +10.6pp |
| Net income |
| 10.01%$1.5B |
| 1.14%$3M |
| TJX +8.9pp |
No disclosed counterparties: LE.
None